
To assess the association between hydroxychloroquine (HCQ) initiation and risk of incident arrhythmia among incident rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) patients. The study identified 11,518 propensity score‐matched RA and SLE individuals in each group. Over the mean follow‐up of eight years, there were 1,610 and 1,646 incident arrhythmias in the HCQ initiator and non‐initiator groups, respectively. The crude incidence rates of arrhythmia were 17.5, and 18.1 per 1,000 person‐years, respectively. The adjusted cause‐specific hazard ratio (cHR) for HCQ initiators was 0.96 compared to non‐initiators. There is no increased risk of arrhythmia among new users of HCQ.
Like
Save
Share